Peter Brett, MD
Peter Brett, MD
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Open-Label Neoadjuvant Pembrolizumab Plus Cetuximab in Betel Nut-Associated Locally Advanced Oral Cavity Squamous Cell Carcinoma | Betel-nut-associated Oral Carcinoma | Not yet recruiting | Phase 2 | 2026-08-10 | NCT07733466 |